A Research Genetic sequencing laboratory
Signed in as:
filler@godaddy.com
A Research Genetic sequencing laboratory
Signed in as:
filler@godaddy.com
This is a Phase I open-label interventional study which will test the efficacy of ResCure™ in the treatment of patients with COVID-19 infection.
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
(Myalgic Encephalomyelitis/
Chronic Fatigue Syndrome)
The investigators propose to ensure a favorable gut microbiome by fecal microbiota transplant to enhance the efficacy Keytruda
The terms REFLORALIZE™ and REFLORALIZATION™ were created by Sabine Hazan, MD, and are Trademarks, reference #19-38771
Copyright © ProgenaBiome™, LLC MMXIX -All Rights Reserved. 2019-2024